MiNK Therapeutics, Inc. Shareholders' Equity
MiNK Therapeutics, Inc. (INKT) had Shareholders' Equity of -$14.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$14.03M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$12.69M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$14.23M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$13.51M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$14.03M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$12.69M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$14.23M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$13.51M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$25.19M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$21.79M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$19.59M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$17.55M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$16.58M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$20.30M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$18.06M 10-K · filed 2026-03-31 | |
| 2023-09-30 | -$13.58M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$9.50M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$4.48M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$401.30K 10-K · filed 2025-03-18 | |
| 2022-09-30 | $6.76M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $13.69M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $17.31M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $23.78M 10-K · filed 2024-03-21 | |
| 2021-09-30 | -$76.51M 10-Q · filed 2022-11-03 | -$76.51M 10-Q · filed 2021-11-29 |
| 2021-06-30 | -$63.18M 10-Q · filed 2022-11-03 | -$63.18M 10-Q · filed 2021-11-29 |
| 2021-03-31 | -$57.08M 10-Q · filed 2022-11-03 | -$57.08M 10-Q · filed 2021-11-29 |
| 2020-12-31 | -$53.87M 10-K · filed 2023-03-24 | -$53.87M 10-Q · filed 2021-11-29 |
| 2020-09-30 | -$51.34M 10-Q · filed 2021-11-29 | |
| 2020-06-30 | -$44.50M 10-Q · filed 2021-11-29 | |
| 2020-03-31 | -$40.06M 10-Q · filed 2021-11-29 | |
| 2019-12-31 | -$36.33M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |